Handelsbanken Fonder’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Buy |
21,600
+500
| +2% | +$10.2K | ﹤0.01% | 1296 |
|
|
2025
Q1 | $383K | Hold |
21,100
| – | – | ﹤0.01% | 1329 |
|
|
2024
Q4 | $533K | Buy |
21,100
+7,300
| +53% | +$184K | ﹤0.01% | 1259 |
|
|
2024
Q3 | $469K | Buy |
13,800
+2,600
| +23% | +$88.4K | ﹤0.01% | 1271 |
|
|
2024
Q2 | $415K | Buy |
11,200
+3,100
| +38% | +$115K | ﹤0.01% | 1238 |
|
|
2024
Q1 | $340K | Hold |
8,100
| – | – | ﹤0.01% | 1337 |
|
|
2023
Q4 | $321K | Buy |
+8,100
| New | +$321K | ﹤0.01% | 1363 |
|
|
2023
Q2 | – | Sell |
-5,800
| Closed | -$209K | – | 1584 |
|
|
2023
Q1 | $209K | Hold |
5,800
| – | – | ﹤0.01% | 1437 |
|
|
2022
Q4 | $259K | Sell |
5,800
-3,100
| -35% | -$138K | ﹤0.01% | 1324 |
|
|
2022
Q3 | $250K | Hold |
8,900
| – | – | ﹤0.01% | 1345 |
|
|
2022
Q2 | $240K | Hold |
8,900
| – | – | ﹤0.01% | 1442 |
|
|
2022
Q1 | $303K | Hold |
8,900
| – | – | ﹤0.01% | 1512 |
|
|
2021
Q4 | $344K | Buy |
+8,900
| New | +$344K | ﹤0.01% | 1564 |
|